CBUI:XETRA:XETRA-iShares MSCI World Value Factor ESG UCITS ETF USD (Acc) (EUR)

ETF | Others |

Last Closing

USD 5.963

Change

+0.04 (+0.59)%

Market Cap

USD 0.26B

Volume

0.12M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-31 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.09 (+0.16%)

USD 445.28B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.02 (+0.13%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.09 (+0.32%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.04 (+0.12%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.09 (+0.33%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.08 (-0.16%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

-0.04 (-0.03%)

USD 98.84B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.11 (+0.20%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+1.06 (+0.99%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+8.32 (+1.35%)

USD 80.38B

ETFs Containing CBUI:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.20% 72% C 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.20% 71% C- 68% D+
Trailing 12 Months  
Capital Gain 17.66% 64% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.66% 63% D 64% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.54% 54% F 54% F
Dividend Return 7.54% 52% F 52% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.48% 68% D+ 75% C
Risk Adjusted Return 88.86% 78% C+ 81% B-
Market Capitalization 0.26B 51% F 45% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike